IPO Rush! experienced mixed activity last week, with Novelis postponing its $878M IPO and Waystar raising $968M. Tempus AI and Telix Pharmaceuticals are set to raise $400M and $200M respectively. Renaissance IPO ETF has gained 4.6% YTD.
Here are some of the other major headlines in the IPO market:
New IPOs Opening This Week:
Telix Pharmaceuticals Raises $201.8M
- Issuing 17M shares at $11.87 per share.
- Australian biotech company.
Tempus AI Raising $399.6M
- Issuing 11.1M shares.
- Estimated price range: $35-$37 per share.
- Developer of AI-based oncology diagnostics.
Kairos Pharma Raising $6.2M
- Offers 1.6M shares at $4 per share.
- Identifies as an oncology drug developer.
WORK Medical Technology Group Raises $9M
- Issues 2M shares.
- Estimated price range: $4–5 per share.
- Based in China.
New Fillings
Alumis (ALMS): A biotech company aiming to raise up to $100M in an IPO.
- EQV Ventures Acquisition (EQVU): A blank check company targeting the energy sector.
- Breathe BioMedical (BRTH): A Canadian medical technology company aiming to raise up to $12M in an IPO.
- UEOPLE Technology Holding (UEOP): A China-based provider of intelligent parking equipment.
- Rising Dragon Acquisition (RDACU): A blank check company targeting small-cap companies in North America, Europe, and the APAC region.